Efficacy and Safety of SPD503 in Combination With Psychostimulants
NCT00734578
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
461
Enrollment
INDUSTRY
Sponsor class
Conditions
ADHD
Interventions
DRUG:
SPD503-AM
DRUG:
SPD503-PM
DRUG:
Placebo
Sponsor
Shire